Inhalex Forte

Inhalex Forte

ipratropium + fenoterol


Teva Pharma


Concise Prescribing Info
Ipratropium Br 0.5 mg, fenoterol HBr 1.25 mg
Acute treatment & prevention of symptoms in COPD w/ reversible bronchospasm eg, bronchial asthma & chronic bronchitis w/ or w/o emphysema.
Dosage/Direction for Use
Adult & childn >12 yr Treatment of attacks 1-2 unit dose. Intermittent & long-term treatment 1 unit dose qid. 
Hypersensitivity to fenoterol HBr or atropine-like substances. Tachyarrhythmia & hypertrophic cardiomyopathy.
Special Precautions
Insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, hyperthyroidism. Prolonged use. Concomitant use w/ β2-agonist, xanthine derivatives, steroids & diuretics. Monitor serum K levels. Patients w/ glaucoma should protect their eyes. Pregnancy (1st trimester) & lactation. Childn <12 yr.
Adverse Reactions
Fine tremor of skeletal muscles, nervousness, palpitations, tachycardia, dizziness or headache. Dryness of the mouth, throat irritation, or allergic reactions, hypokalemia & cough.
Drug Interactions
Effects enhanced by other β-adrenergics, anticholinergics, xanthine derivatives & corticosteroids. Reduced efficacy w/ β-blockers.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03AL01 - fenoterol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
Inhalex Forte inhalation soln
(unit dose) 4 mL x 21 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in